
A health worker measures the dosage of malaria vaccine in Ndhiwa, Homabay County, western Kenya on Sept. 13, 2019 during the launch of a malaria vaccine in Kenya. (AFP/Brian Ogoro)
A vaccine aimed at preventing malaria is currently going through extensive testing to reinvigorate the fight against the mosquito-borne disease in Indonesia. A joint National Research and Innovation Agency (BRIN) team said in its newest report that it had entered the Phase 2 clinical trial of the vaccine, during which it administered a three-dose immunization regime to volunteers.